Related Experiment Video
Updated: Aug 10, 2026

06:24
Minimal Erythema Dose (MED) Testing
Published on: May 28, 2013
Photopatch testing-- a retrospective review using the 1 day and 2 day irradiation protocols
1Leeds Centre for Dermatology, Leeds, UK. rjbatchelor@doctors.org.uk
Contact Dermatitis
|February 21, 2006
Summary
Photopatch testing helps diagnose eczematous eruptions triggered by sunlight. A study found that 2 days of occlusion before allergen irradiation is more sensitive for detecting photoallergy than 1 day.
Area of Science:
- Dermatology
- Photodermatology
- Allergy Testing
Background:
- Photopatch testing investigates eczematous eruptions on sun-exposed skin, especially with a history of sun sensitivity.
- Existing British Photodermatology Group protocols involve allergen irradiation 1 or 2 days post-application, with no proven superiority.
Purpose of the Study:
- To compare the sensitivity of 1-day versus 2-day occlusion periods before allergen irradiation in photopatch testing.
- To evaluate the clinical relevance and indicative nature of photoallergic reactions detected.
Main Methods:
- Retrospective review of photopatch testing records from Leeds over 50 months.
- Allergens applied in triplicate: one set irradiated after 1 day occlusion, another after 2 days; control occluded for 2 days.
- Readings performed at 2 and 4 days post-application.
Main Results:
- 15 of 74 patients had 49 positive results, with 43 deemed clinically relevant.
- 34 positive results indicated photoallergy.
- 2 days occlusion detected more photoallergic reactions (16) compared to 1 day occlusion (5).
Conclusions:
- The study suggests 2 days occlusion before allergen irradiation is more sensitive for detecting photoallergy.
- This finding may refine photopatch testing protocols for improved diagnosis of photoallergic reactions.
More Related Videos
06:21Diffuse Optical Spectroscopy for the Quantitative Assessment of Acute Ionizing Radiation Induced Skin Toxicity Using a Mouse Model
Published on: May 27, 2016
06:31Precision Implementation of Minimal Erythema Dose (MED) Testing to Assess Individual Variation in Human Inflammatory Response
Published on: October 3, 2019